WI Harper Group | December 18, 2020
WI Harper backed Kindstar Global, a leading medical esoteric testing service company based in Beijing, has successfully completed Series E funding. The fundraising round was led by CPE (CITIC Private Equity Funds Management Co., Ltd.), with participation by Investcorp, BOCI (Bank of China International), VMS Group, and ABC International (Agricultural Bank of China International).
Founded in 2003, Kindstar is backed by strong strategic and financial investors including WI Harper Group, Morningside Capital, Baird, Mayo Clinic, and Kleiner Perkins. WI Harper Group led the company’s Series B round in 2011.
“It is a great honor for us to receive such support from well-known, top investors in the medical industry in this round of financing. This is an important milestone for Kindstar Global and it will bring us to the next stage of development as well as grow our momentum,” said Founder and CEO of Kindstar Global Professor Huang Shi Ang. “With this help, we will continue to develop our technology and aim to bring world leading special inspection methods, technologies, and services for both doctors and patients to become a driving force for clinical medical research.”
Mr. Peter Liu, Chairman of WI Harper Group, commented: “WI Harper is honored to be able to grow together with Kindstar Global. As an early investor, for the past 10 years we have witnessed the company’s outstanding performance in the third-party special inspection industry. Their rapid growth in a newly burgeoning sector has made important contributions to the modernization of China’s medical services.”
Kindstar Global (Beijing) Technology, Inc., with laboratory facilities in Beijing, Shanghai and Wuhan, provides esoteric diagnostic testing services to hospitals and physicians covering majority of China. Kindstar is the first and largest esoteric diagnostic testing business in China, providing laboratory testing services to over 3,300 Chinese hospitals, including 930 tertiary hospitals (classification for largest leading hospitals). Kindstar is becoming the partner of choice to physicians in China for advanced diagnostics in many medical specialties including hematology, oncology, infectious diseases and medical genetics. Kindstar is composed of visionary experts team and management team with rich experience, who have worked in the US academic institutes for more than 10 years.
| About WI Harper Group
WI Harper is a pioneer and leading cross-border venture capital firm investing in early and expansion stage companies globally. With offices in San Francisco, Beijing, and Taipei, the firm actively oversees more than $1 billion in assets under management. Since inception nearly three decades ago, WI Harper has invested in over 400 startups and has successfully experienced more than 100 IPO and M&A exits.
We look for innovative companies and visionary founders in healthcare, technology and sustainability fields where there are high synergies and meaningful value-added cross selling opportunities. While our healthcare team is presently honing on bioinformatics and digital biology, our technology team is focused blockchain, big data, analytics, artificial intelligence, AR/VR, IoT, robotics, drones, autonomous driving, as well as digital media and green energy projects.